• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BIO-key International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8/28/24 4:34:27 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology
    Get the next $BKYI alert in real time by email
    bkyi20240828_8k.htm
    false 0001019034 0001019034 2024-08-22 2024-08-22
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
     
    Washington, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): August 22, 2024
     
    BIO-key International, Inc.
    (Exact name of registrant as specified in its charter)
     
    Delaware
    (State or other jurisdiction of incorporation)
    1-13463
    (Commission File Number)
    41-1741861
    (I.R.S. Employer Identification No.)
     
    101 Crawfords Corner Rd, Suite 4116
    Holmdel, NJ 07733
    (Address of principal executive offices)
     
    (732) 359-1100
    (Registrant’s telephone number, including area code)
     
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
     
    ☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐  Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
     
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock
    BKYI
    Nasdaq Capital Market
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
     
       
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 5.07 Submission of Matters to a Vote of Security Holders.
     
    BIO-key International, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on Thursday August 22, 2024. All holders of record of the Company’s common stock outstanding as of the close of business on July 1, 2024 were entitled to vote at the Annual Meeting. At the Annual Meeting, stockholders approved the proposals set forth below. Each of the proposals is more fully described in the Company’s definitive proxy statement, which was filed with the Securities and Exchange Commission on July 10, 2024.
     
    1.         Proposal to elect the following nominees to serve as members of the Company’s board of directors for a one-year term: Michael W. DePasquale, Wong Kwok Fong (Kelvin), Robert J. Michel, Emmanuel Alia, and Cameron E. Williams. Each of the nominees were elected and the final voting results were as follows:
     
    Name
    Votes For
    Withheld
    Broker Non-Votes
           
    Michael DePasquale
    368,965
      98,549
    667,346
    Wong Kwok Fong (Kelvin)
    368,940
      98,574
    667,346
    Robert J. Michel
    368,741
      98,773
    667,346
    Emmanuel Alia
    349,187
    118,327
    667,346
    Cameron E. Williams
    368,582
      98,932
    667,346
     
    2.          Proposal to ratify the selection of Bush & Associates CPA LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2024. The proposal was approved, and the final voting results were as follows:
     
    Votes For
    Votes Against
    Abstentions
    Broker Non-Votes
    831,104
    112,537
    191,219
    0
     
    3.         Proposal to approve, on a non-binding and advisory basis, the compensation paid to the Company’s named executive officers.  The proposal was approved, and the final voting results were as follows:
     
    Votes For
    Votes Against
    Abstentions
    Broker Non-Votes
    302,123
    101,061
    64,330
    667,346
     
    4.         Proposal to approve, on a non-binding and advisory basis, the frequency of the advisory approval of the compensation paid to the Company’s named executive officers.  Submitting the compensation of the Company’s named executive officers for approval each year received the most votes and the final voting results are set forth below. In light of the forgoing vote, the Company has decided to include a shareholder vote on the compensation of its named executive officers in its proxy materials each year until the next required vote on the frequency of shareholder votes on the compensation of the Company’s named executive officers.
     
    1 Year
    2 Years
    3 years
    Abstentions
    Broker Non-Votes
    309,685
    5,879
    10,787
       141,163
    667,346
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    BIO-KEY INTERNATIONAL, INC.
     
    Date: August 28, 2024
         
     
    By:
    /s/ Cecilia C. Welch
     
       
    Cecilia C. Welch
     
       
    Chief Financial Officer
     
     
     
    Get the next $BKYI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BKYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BKYI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bio-key upgraded by Maxim Group with a new price target

    Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00

    3/26/21 7:52:25 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the Period

    HOLMDEL, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, previewed today its business outlook for the first half of 2026 (1H'26) ending June 30, 2026, supported by building software license momentum and strength in hardware revenues. Expected 1H'26 Results: 1H'26 revenues expected to grow 50% to approximately $5M vs. $3.3M in 1H'25Positive net income expected in 1H'26 vs. $1.9M net loss in 1H'25Cash position at the close of 1H'26 is expected to remain in line with $2.7M at year-end 2025 Q1'26 & Q2'26 Expected Revenues: Q1'26 revenues expected to grow 3

    4/16/26 7:59:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET

    HOLMDEL, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its fourth quarter (Q4'25) and year ended December 31, 2025 (2025) results. BIO-key will host an investor call today at 10:00am ET (details below). Highlights:  • 2025 Revenue: $6.1M • 2026 Outlook: Solid revenue growth + improved bottom line • Preliminary Q1'26 Revenue: $2.2M, up 37% vs. Q1'25 and 80% vs. Q4'25 • 2025 Cash Position: $2.7M, up $2.3M vs. $0.4M vs. 2024 BIO-key CEO, Mike DePasquale commented, "We had a broad base of achievements in 2025, the revenue and bottom-line benefits

    3/31/26 8:30:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Identity and Biometric Authentication Cybersecurity Provider BIO-key to Host Year-End Investor Call Tuesday, March 31st at 10am ET

    HOLMDEL, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its 2025 year-end investor call on Tuesday, March 31st at 10 a.m. ET with results issued prior the market opening. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call Details Date / Time:Tuesday, March 31st at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-855-669-9658 U.S. or 1-412-317-0088 Int'l; code 4802902 About BIO-key Internati

    3/25/26 7:58:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Lacous Mira K was granted 2,500 shares, increasing direct ownership by 7% to 38,258 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    1/5/26 4:50:58 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Legal Officer Sullivan James David was granted 2,500 shares, increasing direct ownership by 3% to 97,351 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    1/5/26 4:47:21 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Depasquale Michael W was granted 2,500 shares, increasing direct ownership by 2% to 105,275 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    1/5/26 4:44:50 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 102,775 units (SEC Form 4)

    4/A - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    9/17/25 5:19:52 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 112,174 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    9/17/25 10:47:40 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Legal Officer Sullivan James David bought $7,700 worth of shares (10,000 units at $0.77), increasing direct ownership by 22% to 54,851 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    8/26/25 8:39:25 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    SEC Filings

    View All

    SEC Form NT 10-K filed by BIO-key International Inc.

    NT 10-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    3/31/26 5:23:06 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    3/31/26 8:45:10 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by BIO-key International Inc.

    DEF 14A - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    3/16/26 4:45:30 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Leadership Updates

    Live Leadership Updates

    View All

    BIO-key Partners with SAVIS Group to Bring its Identity and Biometric Authentication Solutions to Vietnam

    HANOI, Vietnam and HOLMDEL, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a leading provider of Identity and Access Management (IAM) and biometric authentication solutions, today announced a strategic partnership with SAVIS Group, one of Vietnam's top information-technology enterprises, specializing in digital signing, identity verification, electronic authentication and cybersecurity services. Vietnam represents one of the most promising markets in Southeast Asia for digital transformation and cybersecurity innovation. The collaboration unites BIO-key's advanced IAM and biometric authentication platforms with SAVIS Group's nationwide experience in dig

    11/17/25 4:00:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Showcases Next-Generation Identity & Biometric Authentication Solutions at Premier Tech and Cybersecurity Events: GITEX 2025 in Dubai and 19ENISE in Spain

    DUBAI, United Arab Emirates and LÉON, Spain and HOLMDEL, N.J. , Oct. 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in biometric-centric Identity and Access Management (IAM) solutions, is proud to announce its participation at two of the most influential cybersecurity and technology events of the year — GITEX Global 2025 in Dubai, U.A.E. and 19ENISE in León, Spain. At both events, BIO-key will demonstrate how its Identity-Bound Biometrics (IBB), PortalGuard® IAM, and Passkey:YOU™ solutions are empowering organisations across government, healthcare, and enterprise sectors to embrace a passwordless, phoneless, and tokenless future. Visitors will exp

    10/15/25 12:01:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers

    DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien

    12/11/23 7:59:02 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Financials

    Live finance-specific insights

    View All

    BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET

    HOLMDEL, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its fourth quarter (Q4'25) and year ended December 31, 2025 (2025) results. BIO-key will host an investor call today at 10:00am ET (details below). Highlights:  • 2025 Revenue: $6.1M • 2026 Outlook: Solid revenue growth + improved bottom line • Preliminary Q1'26 Revenue: $2.2M, up 37% vs. Q1'25 and 80% vs. Q4'25 • 2025 Cash Position: $2.7M, up $2.3M vs. $0.4M vs. 2024 BIO-key CEO, Mike DePasquale commented, "We had a broad base of achievements in 2025, the revenue and bottom-line benefits

    3/31/26 8:30:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Identity and Biometric Authentication Cybersecurity Provider BIO-key to Host Year-End Investor Call Tuesday, March 31st at 10am ET

    HOLMDEL, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its 2025 year-end investor call on Tuesday, March 31st at 10 a.m. ET with results issued prior the market opening. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call Details Date / Time:Tuesday, March 31st at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-855-669-9658 U.S. or 1-412-317-0088 Int'l; code 4802902 About BIO-key Internati

    3/25/26 7:58:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Digital Identity and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 14th at 10am ET

    HOLMDEL, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its third quarter investor call on Friday, November 14th at 10 a.m. ET. Results will be released before the market opens that morning. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and host a Q&A session. Call DetailsDate / Time:Friday, November 14th at 10 a.m. ETCall Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay: 1-855-669-9658 U.S. or 1-412-317-0088 Int'l; code 48

    11/7/25 2:25:56 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by BIO-key International Inc.

    SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    11/14/24 5:05:04 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by BIO-key International Inc.

    SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    2/14/24 3:30:35 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

    SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    2/13/24 8:04:15 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology